Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 1,546

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries

Open access
Zeng, Hongmei, Chen, Wanqing, Zheng, Rongshou, Zhang, Siwei, Ji, John S, Zou, Xiaonong, Xia, Changfa, Sun, Kexin, Yang, Zhixun, Li, He, Wang, Ning, Han, Renqiang, Liu, Shuzheng, Li, Huizhang, Mu, Huijuan, He, Yutong, Xu, Yanjun, Fu, Zhentao, Zhou, Yan, Jiang, Jie, Yang, Yanlei, Chen, Jianguo, Wei, Kuangrong, Fan, Dongmei, Wang, Jian, Fu, Fangxian, Zhao, Deli, Song, Guohui, Chen, Jianshun, Jiang, Chunxiao, Zhou, Xin, Gu, Xiaoping, Jin, Feng, Li, Qilong, Li, Yanhua, Wu, Tonghao, Yan, Chunhua, Dong, Jianmei, Hua, Zhaolai, Baade, Peter, Bray, Freddie, Jemal, Ahmedin, Yu, Xue Qin, He, Jie·2018·The Lancet Global Health

Abstract

BACKGROUND: From 2003 to 2005, standardised 5-year cancer survival in China was much lower than in developed countries and varied substantially by geographical area. Monitoring population-level cancer survival is crucial to the understanding of the overall effectiveness of cancer care. We therefore aimed to investigate survival statistics for people with cancer in China between 2003 and 2015. METHODS: We used population-based data from 17 cancer registries in China. Data for the study population was submitted by the end of July 31, 2016, with follow-up data on vital status obtained on Dec 31, 2015. We used anonymised, individual cancer registration records of patients (aged 0-99 years) diagnosed with primary, invasive cancers from 2003 to 2013. Patients eligible for inclusion had data for demographic characteristics, date of diagnosis, anatomical site, morphology, behaviour code, vital status, and last date of contact. We analysed 5-year relative survival by sex, age, and geographical area, for all cancers combined and 26 different cancer types, between 2003 and 2015. We stratified survival estimates by calendar period (2003-05, 2006-08, 2009-11, and 2012-15). FINDINGS: There were 678 842 records of patients with invasive cancer who were diagnosed between 2003 and 2013. Of these records, 659 732 (97·2%) were eligible for inclusion in the final analyses. From 2003-05 to 2012-15, age-standardised 5-year relative survival increased substantially for all cancers combined, for both male and female patients, from 30·9% (95% CI 30·6-31·2) to 40·5% (40·3-40·7). Age-standardised 5-year relative survival also increased for most cancer types, including cancers of the uterus (average change per calendar period 5·5% [95% CI 2·5-8·5]), thyroid (5·4% [3·2-7·6]), cervix (4·5% [2·9-6·2]), and bone (3·2% [2·1-4·4]). In 2012-15, age-standardised 5-year survival for all patients with cancer was higher in urban areas (46·7%, 95% CI 46·5-47·0) than in rural areas (33·6%, 33·3-33·9), except for patients with oesophageal or cervical cancer; but improvements in survival were greater for patients residing in rural areas than in urban areas. Relative survival decreased with increasing age. The increasing trends in survival were consistent with the upward trends of medical expenditure of the country during the period studied. INTERPRETATION: There was a marked overall increase in cancer survival from 2003 to 2015 in the population covered by these cancer registries in China, possibly reflecting advances in the quality of cancer care in these areas. The survival gap between urban and rural areas narrowed over time, although geographical differences in cancer survival remained. Insight into these trends will help prioritise areas that need increased cancer care. FUNDING: National Key R&D Program of China, PUMC Youth Fund and the Fundamental Research Funds for the Central Universities, and Major State Basic Innovation Program of the Chinese Academy of Medical Sciences.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2214-109x(18)30127-x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 1,546

Metadata

Authors
Zeng, H., Chen, W., Zheng, R., Zhang, S., Ji, J. S., Zou, X., Xia, C., Sun, K., Yang, Z., Li, H., Wang, N., Han, R., Liu, S., Li, H., Mu, H., He, Y., Xu, Y., Fu, Z., Zhou, Y., Jiang, J., Yang, Y., Chen, J., Wei, K., Fan, D., Wang, J., Fu, F., Zhao, D., Song, G., Chen, J., Jiang, C., Zhou, X., Gu, X., Jin, F., Li, Q., Li, Y., Wu, T., Yan, C., Dong, J., Hua, Z., Baade, P., Bray, F., Jemal, A., Yu, X. Q., & He, J.
Venue
The Lancet Global Health
Publisher
Elsevier BV
Published
2018-05
Volume
6
Issue
5
Pages
e555-e567
ISSN
2214-109X (ISSN-L)
OpenAlex
W2797197823
Cited by
1,546
References
6
FWCI
37.16
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries. https://app.cochat.ai/papers/10.1016/s2214-109x(18)30127-x
The paper
Zeng, H., Chen, W., Zheng, R., Zhang, S., Ji, J. S., Zou, X., Xia, C., Sun, K., Yang, Z., Li, H., Wang, N., Han, R., Liu, S., Li, H., Mu, H., He, Y., Xu, Y., Fu, Z., Zhou, Y., . . . He, J. (2018). Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries. The Lancet Global Health. https://doi.org/10.1016/s2214-109x(18)30127-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.